EMMANUEL DUMONT, PHD
Dr. Dumont is a principal investigator at the Jacobs Technion-Cornell Institute in New York City. Dr. Dumont is also the founder and CEO of SHADE, a personalized medicine solution for lupus and skin cancer. SHADE has been backed by the Jacobs Institute, Weill-Cornell Medical College, PCH International, and SilverTech Ventures. Dr. Dumont is also an exhibited artist and the founder of the non-profit Heliotopia which operates in Burkina Faso. Dr. Dumont holds a MS in Mathematics and Physics from Mines de Paris and a PhD in biophysics from Columbia University.